These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33385924)

  • 21. HBM4EU feasibility studies: Lessons learned in combining health and human biomonitoring studies.
    Elonheimo HM; Uusitalo K; Moore S; Andersson AM; Baber R; Wirkner K; David M; Kolossa-Gehring M; Stewart L; Sepai O; Lermen D; Bartel-Steinbach M; Rantakokko P; Koponen J; Tolonen H
    Int J Hyg Environ Health; 2023 Mar; 248():114100. PubMed ID: 36508963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium.
    Roels H; Bernard AM; Cárdenas A; Buchet JP; Lauwerys RR; Hotter G; Ramis I; Mutti A; Franchini I; Bundschuh I
    Br J Ind Med; 1993 Jan; 50(1):37-48. PubMed ID: 8431389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
    Weise P; Apel P; Kolossa-Gehring M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity.
    Roels HA; Hoet P; Lison D
    Ren Fail; 1999; 21(3-4):251-62. PubMed ID: 10416202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
    Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
    Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure.
    Gerofke A; David M; Schmidt P; Vicente JL; Buekers J; Gilles L; Colles A; Bessems J; Bastiaensen M; Covaci A; Den Hond E; Koppen G; Laeremans M; Verheyen VJ; Černá M; Klánová J; Krsková A; Zvonař M; Knudsen LE; Koch HM; Jensen TK; Rambaud L; Riou M; Vogel N; Gabriel C; Karakitsios S; Papaioannou N; Sarigiannis D; Kakucs R; Középesy S; Rudnai P; Szigeti T; Barbone F; Rosolen V; Guignard C; Gutleb AC; Sakhi AK; Haug LS; Janasik B; Ligocka D; Estokova M; Fabelova L; Kolena B; Murinova LP; Petrovicova I; Richterova D; Horvat M; Mazej D; Tratnik JS; Runkel AA; Castaño A; Esteban-López M; Pedraza-Díaz S; Åkesson A; Lignell S; Vlaanderen J; Zock JP; Schoeters G; Kolossa-Gehring M
    Int J Hyg Environ Health; 2023 Jan; 247():114073. PubMed ID: 36434900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated indexes of occupational exposure as predictors of kidney dysfunction.
    Jakubowski M; Trzcinka-Ochocka M; Hałatek T; Raźniewska G; Szymczak W
    Int J Occup Med Environ Health; 2002; 15(4):393-9. PubMed ID: 12608627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PFASs: What can we learn from the European Human Biomonitoring Initiative HBM4EU.
    Uhl M; Schoeters G; Govarts E; Bil W; Fletcher T; Haug LS; Hoogenboom R; Gundacker C; Trier X; Fernandez MF; Calvo AC; López ME; Coertjens D; Santonen T; Murínová ĽP; Richterová D; Brouwere K; Hauzenberger I; Kolossa-Gehring M; Halldórsson ÞI
    Int J Hyg Environ Health; 2023 May; 250():114168. PubMed ID: 37068413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The reference dose for subchronic exposure of pigs to cadmium leading to early renal damage by benchmark dose method.
    Wu X; Wei S; Wei Y; Guo B; Yang M; Zhao D; Liu X; Cai X
    Toxicol Sci; 2012 Aug; 128(2):524-31. PubMed ID: 22610606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for cadmium in urine and blood: Results from the HBM4EU project.
    Nübler S; López ME; Castaño A; Mol H; Schäfer M; Haji-Abbas-Zarrabi K; Bury D; Koch HM; Vaccher V; Antignac JP; Dvorakova D; Hajslova J; Thomsen C; Vorkamp K; Göen T
    Int J Hyg Environ Health; 2021 May; 234():113711. PubMed ID: 33714064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge.
    Rodríguez-Carrillo A; Mustieles V; Salamanca-Fernández E; Olivas-Martínez A; Suárez B; Bajard L; Baken K; Blaha L; Bonefeld-Jørgensen EC; Couderq S; D'Cruz SC; Fini JB; Govarts E; Gundacker C; Hernández AF; Lacasaña M; Laguzzi F; Linderman B; Long M; Louro H; Neophytou C; Oberemn A; Remy S; Rosenmai AK; Saber AT; Schoeters G; Silva MJ; Smagulova F; Uhl M; Vinggaard AM; Vogel U; Wielsøe M; Olea N; Fernández MF
    Int J Hyg Environ Health; 2023 Apr; 249():114140. PubMed ID: 36841007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylmercury Risk Assessment Based on European Human Biomonitoring Data.
    Domínguez-Morueco N; Pedraza-Díaz S; González-Caballero MDC; Esteban-López M; de Alba-González M; Katsonouri A; Santonen T; Cañas-Portilla A; Castaño A
    Toxics; 2022 Jul; 10(8):. PubMed ID: 36006106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term effect of cadmium exposure on residents' renal dysfunction: An epidemiologic study].
    Zhang Y; Liang X; Chen W; Wang J; Huang Q; Chen Z; Wang P; Huang R; Hu S; Li Z; Tang L; Wang G; Yang F; Li X; Zhao Y; Yang X; Wu Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jul; 49(7):638-43. PubMed ID: 26310478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad).
    Jin T; Nordberg M; Frech W; Dumont X; Bernard A; Ye TT; Kong Q; Wang Z; Li P; Lundström NG; Li Y; Nordberg GF
    Biometals; 2002 Dec; 15(4):397-410. PubMed ID: 12405535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiologic study of renal function in copper smelter workers.
    Lilis R; Valciukas JA; Weber JP; Malkin J; Selikoff IJ
    Environ Health Perspect; 1984 Mar; 54():181-92. PubMed ID: 6376092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational exposure to cadmium and kidney dysfunction.
    Jakubowski M; Trojanowska B; Kowalska G; Gendek E; Starzyński Z; Krajewska B; Jajte J
    Int Arch Occup Environ Health; 1987; 59(6):567-77. PubMed ID: 3679555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between Urinary Excretion of Cadmium and Renal Biomarkers in Nonsmoking Females: A Cross-Sectional Study in Rural Areas of South China.
    Zhang YR; Wang P; Liang XX; Tan CS; Tan JB; Wang J; Huang Q; Huang R; Li ZX; Chen WC; Wu SX; Ong CN; Yang XF; Wu YN
    Int J Environ Res Public Health; 2015 Sep; 12(10):11988-2001. PubMed ID: 26404328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-exposure to lead increases the renal response to low levels of cadmium in metallurgy workers.
    Hambach R; Lison D; D'Haese PC; Weyler J; De Graef E; De Schryver A; Lamberts LV; van Sprundel M
    Toxicol Lett; 2013 Oct; 222(2):233-8. PubMed ID: 23806787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reassessment of critical lead effects by the German Human Biomonitoring Commission results in suspension of the human biomonitoring values (HBM I and HBM II) for lead in blood of children and adults.
    Wilhelm M; Heinzow B; Angerer J; Schulz C
    Int J Hyg Environ Health; 2010 Jul; 213(4):265-9. PubMed ID: 20493765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.